Dăniluc, L.; Braha, A.; Sandu, O.E.; Bogdan, C.; Suhov, L.; Haj Ali, L.; Lazăr-Höcher, A.-I.; Sima, A.; Apostol, A.; Ivan, M.V.
Subclinical Changes in Type 2 Diabetes Patients with Heart Failure Stage A and B Treated with Oral Semaglutide. Medicina 2025, 61, 567.
https://doi.org/10.3390/medicina61040567
AMA Style
Dăniluc L, Braha A, Sandu OE, Bogdan C, Suhov L, Haj Ali L, Lazăr-Höcher A-I, Sima A, Apostol A, Ivan MV.
Subclinical Changes in Type 2 Diabetes Patients with Heart Failure Stage A and B Treated with Oral Semaglutide. Medicina. 2025; 61(4):567.
https://doi.org/10.3390/medicina61040567
Chicago/Turabian Style
Dăniluc, Larissa, Adina Braha, Oana Elena Sandu, Carina Bogdan, Loredana Suhov, Lina Haj Ali, Alexandra-Iulia Lazăr-Höcher, Alexandra Sima, Adrian Apostol, and Mihaela Viviana Ivan.
2025. "Subclinical Changes in Type 2 Diabetes Patients with Heart Failure Stage A and B Treated with Oral Semaglutide" Medicina 61, no. 4: 567.
https://doi.org/10.3390/medicina61040567
APA Style
Dăniluc, L., Braha, A., Sandu, O. E., Bogdan, C., Suhov, L., Haj Ali, L., Lazăr-Höcher, A.-I., Sima, A., Apostol, A., & Ivan, M. V.
(2025). Subclinical Changes in Type 2 Diabetes Patients with Heart Failure Stage A and B Treated with Oral Semaglutide. Medicina, 61(4), 567.
https://doi.org/10.3390/medicina61040567
